Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic Emergence of different phenotypes of thrombotic disease?

Daniela Husser, Sven Hohenstein, Vincent Pellissier, Sebastian König, Laura Ueberham, Gerhard Hindricks, Andreas Meier-Hellmann, Ralf Kuhlen, View ORCID ProfileAndreas Bollmann
doi: https://doi.org/10.1101/2021.02.08.21250291
Daniela Husser
1Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven Hohenstein
1Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Pellissier
1Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian König
1Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Ueberham
1Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerhard Hindricks
1Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Meier-Hellmann
2Helios Kliniken, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralf Kuhlen
3Helios Health, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Bollmann
1Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andreas Bollmann
  • For correspondence: andreas.bollmann@helios-gesundheit.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background There is discussion evolving around the emergence of different phenotypes of Covid-19-associated thromboembolic disease, i.e. acute pulmonary embolism vs pulmonary thrombosis and different phenotypes of in situ thrombosis. With this study, we wish to provide hospitalization, treatment and in-hospital outcome data for pulmonary embolism during the 2020 Covid-19 pandemic and a corresponding 2016 – 2019 control period.

Methods We performed a retrospective analysis of claims data of Helios hospitals in Germany. Consecutive cases with a hospital admission between January 1 and December 15, 2020 and pulmonary embolism as primary discharge diagnosis were analyzed and compared to a corresponding period covering the same weeks in 2016 – 2019.

Results As previously reported for other emergent medical conditions, there was a hospitalization deficit coinciding with the 1st pandemic wave. Beginning with the 12-week interval May 6 – July 28, there was a stable surplus of hospital admissions in 2020. During this surplus period (May 6 – December 15, 2020), there were 2,449 hospitalizations including 45 PCR-confirmed Covid-19 cases (1.8%) as opposed to 8,717 in 2016 – 2019 (IRR 1.12, 95% CI 1.07 – 1.18, P<0.01). When excluding Covid-19 cases IRR was 1.10 (95% CI 1.05 – 1.15, P<0.01). While overall comorbidities expressed as weighted AHRQ Elixhauser Comorbidity Index (14.1 ± 10.1 vs. 13.9 ±10.3, P=0.28), the presence of thrombosis (46.1 vs 45.4%, P=0.55) and surgery (3.8 vs. 4.3%, P=0.33) were comparable, coagulopathy (3.3 vs 4.5%, P=0.01) and metastatic cancer (3.0 vs 4.0%, P=0.03) as contributing factors were less frequently observed during the 2020 surplus. Interventional treatments (thrombolytic therapy, thrombectomy or inferior vena cava filter placement) were less frequently used (4.7 vs 6.6%, OR 0.72, 95% CI 0.58 − 0.89, P< 0.01). Similarly, intensive care (35.1 vs 38.8%, OR 0.83, 95% CI 0.75 − 0.92, P< 0.01) and mechanical ventilation utilization (7.2 vs 8.1%, OR 0.88, 95% CI 0.74 – 1.04, P=0.14) as well as in-hospital-mortality rates (7.8 vs 9.8%, OR 0.76, 95% CI 0.64 − 0.90, P< 0.01) were lower in 2020 compared with 2016 – 2019. This was associated with a shorter length of hospital stay (6.4 ±5.4 vs. 7.2 ±5.7 days, P< 0.01) during the 2020 surplus period.

Conclusions Only a minority of cases were associated with PCR-confirmed Covid-19 but this does not rule out preceding or undetected SARS-CoV-2 infection. Although there is a shift towards milder disease course, the increased incidence of hospitalizations for pulmonary embolism requires immediate attention, close surveillance and further studies.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding was received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Ethics Committee at the Medical Faculty, Leipzig University (#490/20-ek). Due to the retrospective study of anonymized data informed consent was not obtained.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Conflicts of interest: none declared

Data Availability

The data that support the findings of this study are available on request from the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 11, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic Emergence of different phenotypes of thrombotic disease?
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic Emergence of different phenotypes of thrombotic disease?
Daniela Husser, Sven Hohenstein, Vincent Pellissier, Sebastian König, Laura Ueberham, Gerhard Hindricks, Andreas Meier-Hellmann, Ralf Kuhlen, Andreas Bollmann
medRxiv 2021.02.08.21250291; doi: https://doi.org/10.1101/2021.02.08.21250291
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic Emergence of different phenotypes of thrombotic disease?
Daniela Husser, Sven Hohenstein, Vincent Pellissier, Sebastian König, Laura Ueberham, Gerhard Hindricks, Andreas Meier-Hellmann, Ralf Kuhlen, Andreas Bollmann
medRxiv 2021.02.08.21250291; doi: https://doi.org/10.1101/2021.02.08.21250291

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cardiovascular Medicine
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (49)
  • Cardiovascular Medicine (448)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (190)
  • Epidemiology (5214)
  • Forensic Medicine (3)
  • Gastroenterology (194)
  • Genetic and Genomic Medicine (749)
  • Geriatric Medicine (76)
  • Health Economics (212)
  • Health Informatics (694)
  • Health Policy (352)
  • Health Systems and Quality Improvement (222)
  • Hematology (98)
  • HIV/AIDS (162)
  • Infectious Diseases (except HIV/AIDS) (5814)
  • Intensive Care and Critical Care Medicine (356)
  • Medical Education (102)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (758)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (231)
  • Oncology (475)
  • Ophthalmology (149)
  • Orthopedics (38)
  • Otolaryngology (93)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (139)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (853)
  • Public and Global Health (1992)
  • Radiology and Imaging (343)
  • Rehabilitation Medicine and Physical Therapy (156)
  • Respiratory Medicine (283)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (75)
  • Surgery (108)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)